Catalyst Research Management Group

Catalyst Clinical Research is a global clinical research organization (CRO) providing full-service and functional service provider (FSP) solutions to the biopharmaceutical industry. The company was formed through the merger of Catalyst Clinical Research and Catalyst Research Management Group (Catalyst RMG) in 2019, combining expertise in oncology and complex clinical trial management. Catalyst specializes in oncology, rare diseases, and other specialized therapeutic areas, offering a flexible "Catalyst Flex" model for FSP services and "Catalyst Full" for end-to-end trial management. Headquartered in Wilmington, North Carolina, the firm is backed by private equity firm NovaQuest Capital Management and focuses on providing highly customized clinical development solutions for small to mid-sized biotech companies.